95076

Ingestion challenge test (sequential and incremental ingestion of test items, e.g., food, drug or other substance); initial 120 minutes of testing

The CPT code 95076 represents the ingestion challenge test, which is universally recognized as the gold standard in allergy and immunology for confirming or ruling out food, drug, or other substance allergies. This procedure involves the sequential and incremental oral administration of a suspected allergen to a patient under strictly controlled and highly supervised clinical conditions. The primary objective is to observe whether the patient develops a clinical allergic reaction, which establishes a definitive diagnosis, or to prove tolerance, which allows the safe reintroduction of the substance into the patient diet or medication regimen. Because the ingestion challenge carries a significant inherent risk of provoking a severe systemic allergic reaction, including life threatening anaphylaxis, it requires the continuous physical presence and direct supervision of a physician or a similarly qualified healthcare professional. Before initiating the test, a comprehensive baseline clinical assessment is conducted, and informed consent is meticulously obtained. The clinical environment must be fully equipped with emergency resuscitation supplies, including injectable epinephrine, antihistamines, bronchodilators, oxygen, and intravenous fluids. The testing protocol typically begins with administering a minute, subclinical dose of the suspected allergen. The patient is then continuously monitored for a predetermined interval, usually ranging from fifteen to thirty minutes. During this observation phase, the clinician diligently checks for subjective and objective signs of hypersensitivity, such as cutaneous manifestations like urticaria or erythema, gastrointestinal symptoms, respiratory distress, wheezing, or hemodynamic instability. If the patient tolerates the initial dose without any adverse effects, progressively larger doses are administered sequentially, each followed by a similar observation period. This meticulous process continues until either the patient successfully consumes a standard age appropriate serving of the food or a therapeutic dose of the drug, or until objective clinical symptoms of an allergic reaction manifest. If a reaction occurs, the challenge is immediately terminated, and appropriate pharmacological interventions are administered promptly to stabilize the patient. The CPT code 95076 specifically accounts for the initial one hundred and twenty minutes of this intensive testing process. The time is calculated from the start of the first dose administration through the completion of the final post dose observation period. It is critical to note that if the total testing time falls short of sixty one minutes, this code should not be utilized; instead, a standard Evaluation and Management code should be reported. For prolonged challenges that extend beyond the initial two hour window, an add on code is utilized in conjunction with 95076 to capture the additional time and clinical effort expended. This rigorous and highly specialized diagnostic tool is invaluable in modern clinical practice, preventing unnecessary dietary restrictions, optimizing pharmacological therapies, and significantly improving the overall quality of life and safety of patients with suspected hypersensitivity disorders.

Clinical Indications

  • Suspected food allergy requiring diagnostic confirmation or exclusion.
  • Suspected drug allergy or hypersensitivity requiring verification.
  • Assessment of allergy resolution to determine if a patient has outgrown a previously diagnosed food allergy.
  • Evaluation of potential cross-reactivity between related allergenic substances.
  • Determining a safe threshold dose for an allergen to guide dietary or pharmacological management.

Procedure Steps

  1. Perform a comprehensive baseline clinical assessment, including vital signs and pulmonary auscultation.
  2. Obtain formal informed consent and verify that emergency resuscitation equipment and medications are immediately accessible.
  3. Prepare the specific test substance in carefully measured, incremental doses according to an established protocol.
  4. Administer the initial, lowest predetermined dose of the test substance orally to the patient.
  5. Observe the patient continuously for a specific time interval, typically 15 to 30 minutes, assessing for any signs of an allergic reaction.
  6. Administer progressively larger doses sequentially if no adverse reaction occurs, with each dose followed by a dedicated observation interval.
  7. Monitor vital signs and clinical status continuously throughout the entire testing period.
  8. Conclude the ingestion challenge either when the target therapeutic or normal dietary dose is achieved without reaction, or halt the test immediately and initiate emergency treatment if an objective allergic reaction occurs.

Coding Guidelines

  • Report CPT code 95076 for the initial 120 minutes of the ingestion challenge testing.
  • Time is calculated continuously from the start of the first dose administration to the end of the final observation period.
  • Do not report 95076 if the total testing time is 60 minutes or less; report an appropriate Evaluation and Management code instead.
  • Report add-on CPT code 95079 for each additional 60 minutes of testing beyond the initial 120 minutes.
  • Code 95076 is reported only once per date of service.
  • Testing requires the continuous physical presence of a physician or other qualified healthcare professional.
  • Do not report 95076 in conjunction with 99202-99215 unless the E/M service is significant, separately identifiable, and medically necessary, requiring modifier 25.

Associated ICD-10 Codes